Indiana University Simon Cancer Center — Indianapolis, Indiana

Indiana University Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University Simon Cancer Center has participated in 89 clinical trials with 9 currently active.

Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.

Sponsors: Seagen Inc., SCRI Development Innovations, LLC, Threshold Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

• Community Regional Cancer Care at Community Hospital East
• Indiana University Health University Hospital /ID# 259827
• Riley Child & Adolescent Psychiatry Clinic- Riley Hospital
• Indiana University (IU) School of Medicine
• The Rehabilitation Hospital of Indiana
• Wishard Memorial Hospital
• Indiana University Health, Neurorehabilitation & Robotics
• Indiana University Hospital, Indiana Clinical Research Center, 550 North University Boulevard (Site 840014)
• Indiana University Health Simon Cancer Center
• Indiana University Cancer Center Clinical Research Office
• Indiana University Indiana Univ
• IU Medical Center / Riley Hospital

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Simon Cancer Center?

Indiana University Simon Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Simon Cancer Center conducted?

Indiana University Simon Cancer Center has 89 clinical trials on record, with 9 currently active. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.

Is Indiana University Simon Cancer Center accredited by Crixeo Clinical Trials?

Indiana University Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.